Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Argus Health
Dow
Colorcon
AstraZeneca
Daiichi Sankyo
Chubb
Boehringer Ingelheim
Teva

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,722,735

« Back to Dashboard

Which drugs does patent 8,722,735 protect, and when does it expire?

Patent 8,722,735 protects IZBA and is included in one NDA.

This patent has thirty patent family members in twenty countries.
Summary for Patent: 8,722,735
Title:Pharmaceutical compositions having desirable bioavailability
Abstract: The present invention is directed to the provision of pharmaceutical compositions. The compositions include a therapeutic agent and a relatively low amount of surfactant for providing higher bioavailability of the therapeutic agent. The compositions are particularly desirable as ophthalmic compositions in which the therapeutic agent is a prostaglandin such as travoprost and the surfactant is a vegetable oil such as castor oil.
Inventor(s): Kabra; Bhagwati P. (Euless, TX), Carreras; Nuria (Barcelona, ES), Cuchi; Monica (Barcelona, ES), Galan; Francisco Javier (Teia, ES), Mridvika; (Barcelona, ES), Puig; Elena Gonzalez (Barcelona, ES), Jimenez; Nuria (Barcelona, ES), Martinez; Carmen (Barcelona, ES)
Assignee: Alcon Research, Ltd. (Fort Worth, TX)
Application Number:13/252,255
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,722,735
Patent Claim Types:
see list of patent claims
Composition; Formulation;

Drugs Protected by US Patent 8,722,735

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Novartis Pharms Corp IZBA travoprost SOLUTION/DROPS;OPHTHALMIC 204822-001 May 15, 2014 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,722,735

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,144,561 Pharmaceutical compositions having desirable bioavailability ➤ Try a Free Trial
8,178,582 Pharmaceutical compositions having desirable bioavailability ➤ Try a Free Trial
8,754,123 Pharmaceutical compositions having desirable bioavailability ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 8,722,735

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Taiwan I544927 ➤ Try a Free Trial
Taiwan 200940068 ➤ Try a Free Trial
Slovenia 2265251 ➤ Try a Free Trial
Russian Federation 2503453 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Johnson and Johnson
Federal Trade Commission
Harvard Business School
McKinsey
Deloitte
Fish and Richardson
Teva
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.